Samsung Medical Center
Clinical trials sponsored by Samsung Medical Center, explained in plain language.
-
Could a few days of radiation beat weeks for recurrent prostate cancer?
Disease control Recruiting nowThis study is for men whose prostate cancer has come back after surgery, shown by rising PSA levels. It compares a standard few weeks of radiation to a much shorter course of just a few days. The goal is to see if the shorter option works just as well to control the cancer while …
Phase: PHASE3 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 26, 2026 11:48 UTC
-
Heart stent showdown: new drug combo may beat standard care
Disease control Recruiting nowThis study tests whether a stronger blood thinner (prasugrel) combined with aspirin works better than the standard combination of clopidogrel and aspirin for people with coronary artery disease who need complex stents. About 3,500 adults will be randomly assigned to one of the tw…
Phase: PHASE4 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 26, 2026 11:45 UTC
-
Heart patients may ditch daily blood thinners after new procedure
Disease control Recruiting nowThis study looks at whether people with chronic heart disease and a high risk of bleeding can safely stop taking antiplatelet drugs (blood thinners) after a special balloon treatment called drug-coated balloon angioplasty. Participants must have been stable for at least a year af…
Phase: NA • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 26, 2026 11:44 UTC
-
Can a daily pill keep lung spots from turning into cancer?
Disease control Recruiting nowThis study tests whether the drug osimertinib can stop or shrink small, hazy lung spots (called GGNs) that remain after surgery for a type of lung cancer. About 59 adults with EGFR-mutated lung cancer will take a daily pill for a period of time. The goal is to see if the drug pre…
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 26, 2026 11:44 UTC
-
Targeted drug shows promise for rare Gene-Driven cancers
Disease control Recruiting nowThis study tests a drug called patritumab deruxtecan in 30 adults with advanced solid tumors that have a rare NRG1 gene fusion. The drug targets a protein on cancer cells to stop their growth. The main goal is to see how many patients' tumors shrink or disappear.
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 26, 2026 11:44 UTC
-
Simple zapping vs. cutting: which is better for tiny stomach polyps?
Disease control Recruiting nowThis study compares two procedures for removing small precancerous growths (≤1 cm) in the stomach: argon plasma coagulation (APC), a simpler, non-contact method, and endoscopic mucosal resection (EMR), which cuts out the tissue. About 160 adults with low-grade dysplasia will be r…
Phase: NA • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 26, 2026 11:35 UTC
-
New combo therapy aims to keep rare urinary tract cancer at bay
Disease control Recruiting nowThis study tests whether giving the immunotherapy drug avelumab after standard chemotherapy can help prevent upper tract urothelial cancer from coming back. About 48 adults who have already completed chemotherapy and show no signs of cancer will receive avelumab as a maintenance …
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 26, 2026 11:34 UTC
-
Balloon vs stent: which is better for tricky heart blockages?
Disease control Recruiting nowThis study tests whether a drug-coated balloon works better than a drug-eluting stent for treating complex blockages in heart arteries. About 520 adults with coronary artery disease will be randomly assigned to one of the two procedures. The main goal is to see which approach red…
Phase: NA • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 26, 2026 11:34 UTC
-
New pill may prevent lung spots from turning into cancer after surgery
Disease control Recruiting nowThis study tests whether the drug osimertinib can stop small, hazy spots (called GGNs) left in the lungs from growing after surgery for a type of lung cancer. It includes 43 adults with stage I lung cancer and a specific gene mutation. Participants take a daily pill for one year,…
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 26, 2026 11:32 UTC
-
AI takes on invasive heart test in major trial
Disease control Recruiting nowThis study compares a new AI-driven method (MPFFR) against the standard invasive FFR test to decide if and where to place stents in blocked heart arteries. About 2,100 adults with coronary artery disease will be randomly assigned to one of the two approaches. The goal is to see i…
Phase: NA • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 26, 2026 11:32 UTC
-
Heart attack patients may ditch daily pills, major trial investigates
Disease control Recruiting nowThis study looks at whether people who have had a heart attack but do not have heart failure can safely stop taking beta-blockers after at least one year. About 2,540 adults will be randomly assigned to either stop or continue the medication. The goal is to see if stopping is jus…
Phase: PHASE4 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 26, 2026 11:30 UTC
-
Can early action tame hidden heart flutters?
Disease control Recruiting nowThis study looks at whether starting treatment early for atrial fibrillation (AF) that is only detected by heart devices can reduce the amount of AF or prevent it from becoming a full-blown condition. About 520 adults with heart devices will be split into two groups: one gets ear…
Phase: NA • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 26, 2026 11:29 UTC
-
New hope for lung cancer patients whose treatment stopped working
Disease control Recruiting nowThis study tests a combination of two targeted drugs, lazertinib and tepotinib, in people with a specific type of advanced lung cancer (EGFR-mutant non-small cell lung cancer) that has stopped responding to lazertinib alone due to a change in the MET gene. About 47 participants w…
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 26, 2026 11:29 UTC
-
Pacemaker study aims to find best spot for heart pacing
Disease control Recruiting nowThis study looks at two different places to put a pacemaker lead in people with sick sinus syndrome. The goal is to see which spot—Bachmann's bundle or the right atrial appendage—better protects the heart's upper chambers from damage. Researchers will track heart structure and fu…
Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 26, 2026 11:08 UTC
-
Tailored brain zaps aim to get Parkinson's patients moving better
Symptom relief Recruiting nowThis study tests whether a personalized form of brain stimulation (rTMS) can improve walking and movement in people with Parkinson's disease better than the standard one-size-fits-all approach. Researchers will tailor the stimulation target based on each patient's brain function.…
Phase: NA • Sponsor: Samsung Medical Center • Aim: Symptom relief
Last updated May 26, 2026 11:33 UTC
-
Tailored brain zaps may boost arm recovery in stroke patients
Symptom relief Recruiting nowThis study tests whether personalized brain stimulation (rTMS) can improve arm and hand movement in people who recently had a stroke. About 120 participants will receive either standard or customized stimulation based on their individual brain reserve. The goal is to see if a tai…
Phase: NA • Sponsor: Samsung Medical Center • Aim: Symptom relief
Last updated May 26, 2026 11:08 UTC
-
CT scans may reveal who responds best to Pre-Surgery lung cancer therapy
Knowledge-focused Recruiting nowThis study looks at whether chest CT scans can help predict how well lung cancer responds to chemoimmunotherapy given before surgery. Researchers will compare CT images taken before and after treatment with actual tumor tissue removed during surgery. The goal is to develop a noni…
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 11:49 UTC
-
New study aims to make PICU care more personal for kids and families
Knowledge-focused Recruiting nowThis study is developing and testing a goal-setting strategy for children in the pediatric intensive care unit (PICU). Researchers will work with experts and families to create a tool that helps set meaningful goals based on what matters most to the child and their caregivers. Th…
Phase: NA • Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 11:48 UTC
-
New study aims to predict cancer recurrence in kidney and ureter cancer patients
Knowledge-focused Recruiting nowThis study follows 300 Korean adults with high-grade upper tract urothelial carcinoma to monitor for cancer recurrence after chemotherapy and surgery. Researchers collect blood samples and medical data over time to build a platform that may help predict when the cancer comes back…
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 11:45 UTC
-
Lung cancer patients screened for genetic clues to future treatments
Knowledge-focused Recruiting nowThis study screens up to 797 people with relapsed small cell lung cancer to identify genetic changes in their tumors. No experimental drugs are given; instead, researchers analyze tissue and blood samples to classify cancer subtypes. The goal is to prepare for future trials that …
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 11:45 UTC
-
New study aims to unlock mysteries of rare immune disorder in adults
Knowledge-focused Recruiting nowThis study is for adults with hemophagocytic lymphohistiocytosis (HLH), a rare condition where the immune system becomes overactive and damages the body. Researchers want to learn more about how the disease behaves in adults and how patients respond to standard treatments like st…
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 11:44 UTC
-
New study aims to unlock secrets of head and neck cancer in korean patients
Knowledge-focused Recruiting nowThis study is collecting medical information and tissue samples from 350 adults with head and neck cancer at Samsung Medical Center. Researchers want to understand why some patients respond better to treatment than others. The goal is to find biological markers that can help doct…
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 11:33 UTC
-
New study tests if heart scans can save lives after stents
Knowledge-focused Recruiting nowThis study looks at whether a special heart scan (coronary CT angiography) is better than standard follow-up care for high-risk patients who have had a stent placed to open blocked arteries. About 3,500 adults aged 19 and older with complex heart conditions will be enrolled. The …
Phase: NA • Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC